Topical Steroid Withdrawal — What Your Patients Are Watching Online Topical steroid withdrawal (TSW) is an increasingly visible — and misunderstood — drug‑related dermatosis that can follow abrupt discontinuation of…
Read More
Rethinking AD — Beyond Inflammation Atopic dermatitis remains common and stubborn, especially in pediatric patients, because inflammation is only one part of a self‑reinforcing loop that includes microbiome disruption, neuroimmune…
Read More
Meet Dr. Theodore (Ted) J. Daly Theodore (Ted) J. Daly MD has been in private practice at Garden City Dermatology, New York, for nearly four decades. He received his medical…
Read More
From the Vault: Novel Strategy for Strengthening Dermatoporotic Skin by Managing Cellular Senescence
Microdosed Actives Target Dermal Senescence - A Surprising Lab Advance That Could Reshape Dermatoporosis Care Dermatoporosis —age‑related thinning and fragility of the skin driven by fibroblast dysfunction, ECM breakdown, and…
Read More
Influenza Vaccination and Arm Nodules: Uncovering a Hidden Risk A large propensity-matched cohort study using TriNetX data found that intramuscular influenza vaccination carries a 32% higher risk of developing subcutaneous…
Read More
Sunscreen ... our daily epi/dermal defense, our solar safeguard, our broad-spectrum BFF for life. Yet lurking in the shaded areas are unfounded fears: “Sunscreen causes cancer; Sunscreen is an endocrine…
Read More
Dermatology On-Call Data Uncover Trends in Hematology–Oncology Cutaneous Complications Oncodermatology consults for hematological malignancy patients often uncover therapy-related skin toxicities that can derail cancer treatment. In a retrospective review of…
Read More
Curated by the JDD Editors Missed any of our October highlights? October is our Atopic Dermatitis focused issue–start to dive in! Catch up with this curated roundup from the JDD…
Read More
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Read More
Check Out JDD Corner's Latest Author Spotlight Our current Author Spotlight features Omar Ibrahimi MD PhD and Catherine Di Giorgio MD, two of the co-authors who ran the clinical trials for…
Read More
Fast itch relief and comparable skin clearance at week 4 - a nonsteroidal option to note for mild-moderate AD In a phase 2, dose‑ranging trial, twice‑daily 1.5% ruxolitinib cream matched…
Read More
A simple 1% colloidal oatmeal regimen cut itch and improved eczema scores within days in toddlers A small open‑label study in children aged 3-72 months tested a twice‑daily 1% colloidal…
Read More
